Open Access
ARTICLE
Jianming Wang, Qiguang Wang*, Xiaotang Sheng, Jingsong Geng, Jiawang Xiao, Xianyang Zhu*
Congenital Heart Disease, DOI:10.32604/chd.2022.021855
Abstract Objective: This study was designed to determine the long-term safety and efficacy of using the Amplatzer Duct
Occluder II (ADO II) for the closure of various ventricular septal defects (VSDs). Methods: From January 2011 to
December 2019, selected VSD patients were treated through transcatheter intervention using ADO II occluders.
The closure results and complications from 188 patients, involving 167 perimembranous ventricular septal defects
(pmVSDs), 9 intracristal VSDs, 11 post surgery residual shunts and 1 post closure residual shunt with the mean
outlet diameter3.1 ± 0.8 mm under angiography, were enrolled in this study. Results: The success rate was 98.9%
for… More >
Open Access
ARTICLE
Efrén Martínez-Quintana1,2,*, Hiurma Estupiñán-León2, Ana Beatriz Rojas-Brito2, Liuva Déniz-Déniz2, Alejandro Barreto-Martín2, Fayna Rodríguez-González3
Congenital Heart Disease, DOI:10.32604/CHD.2021.013308
Abstract Background: Living well is as important as living longer. The objective of this study is to assess quality of life
(QoL) in congenital heart disease (CHD) according to current AHA/ACC anatomical and physiological classifi-
cation. Methods: Cross-sectional study examining the World Health Organization QoL Bref questionnaire
(WHOQoL-Bref) in consecutive outpatient CHD patients from a single unit. Results: 191 CHD patients were
studied. Median age was 28 ± 13 years and 59% were male. 44 (23%), 115 (60%) and 33 (17%) CHD patients
showed mild, moderate and great anatomical defects respectively while 69 (36%) patients were in physiological
Stage A, 27… More >